Fig. 1From: Preventing the adverse cardiovascular consequences of allogeneic stem cell transplantation with a multi-faceted exercise intervention: the ALLO-Active trial protocolOverview of the ALLO-Active trial design. A comprehensive battery of tests will be conducted in both groups during pre-transplant (baseline) and end of study testing (12-week post-discharge), while an abbreviated version of testing will be performed at post-inpatient testing (detailed in Table 3)Back to article page